Kyntra Bio (KYNB) Long-Term Investments (2014 - 2026)

Kyntra Bio has reported Long-Term Investments for 13 years, with the latest figure at $8.0 million in Q1 2026.

• Quarterly Long-Term Investments changed N/A year-over-year to $8.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $8.0 million (changed N/A YoY) and the FY2025 annual result came in at $20.2 million, changed N/A from the prior year.
• Long-Term Investments eased to $8.0 million in Q1 2026 per KYNB's latest filing, from $20.2 million in the prior quarter.
• Over five years, Long-Term Investments peaked at $20.2 million in Q4 2025 and troughed at $3.0 million in Q3 2025.
• A 5-year average of $6.4 million and a median of $5.5 million in 2023 frame the typical range for Long-Term Investments.
• The sharpest annual moves came in 2022 and 2023: Long-Term Investments tumbled 95.62% in 2022, then soared 41.61% in 2023.
• Over 5 years, Long-Term Investments stood at $5.1 million in 2022, then increased by 4.52% to $5.3 million in 2023, then gained by 9.75% to $5.8 million in 2024, then soared by 247.23% to $20.2 million in 2025, then plunged by 60.19% to $8.0 million in 2026.
• According to Business Quant data, Long-Term Investments over the past three periods registered $8.0 million, $20.2 million, and $3.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.